Archived Seminar: Engineering the Bio/Nano Interface for Enhanced Nano-Immunotherapy
Pioneers in Biomedical Research Seminar presented by the Fralin Biomedical Research Institute at VTC
Archived Seminar: Engineering the Bio/Nano Interface for Enhanced Nano-Immunotherapy
Date: Nov. 13, 2020
Time: 11:00 a.m. - 12:00 p.m.
About This Seminar
Self-assembled nanobiomaterials that are engineered to achieve specific biodistributions and mechanisms of degradation hold great promise for controlled stimulation of the immune system. Taking advantage of the morphological flexibility of self-assembled systems, we aim to mimic various structures and biochemical mechanisms of pathogens to enhance cell-selective intracellular delivery and treatment efficacy during immunotherapy. Dr. Scott and his team specifically approach this by synthesizing, assembling and optimizing in vitro and in vivo a range of nanostructures loaded with strategically selected combinations of immunostimulants to achieve controlled activation or suppression of the immune system. Dr. Scott will present some of our ongoing work in the area of novel nanobiomaterials development and interactions at the bio/nano interface, as well as recent applications of our materials for the controlled modulation of cells for a variety of therapeutic applications, including cell/organ transplantation, vaccination, and treatment of atherosclerosis, glaucoma and infectious diseases.
Additional Details
This is a free event hosted by the Fralin Biomedical Research Institute and co-sponsored by the institute's Cancer Research Group. The Fralin Biomedical Research Institute Pioneers in Biomedical Research Program offers the expertise of a range of scientists who are exploring frontiers in biomedical research. These seminars are open to Virginia Tech and Carilion Clinic faculty, students, and staff.
You May Also Be Interested In...
-
Home Item
A Human-Centric View of Cerebellar Development , homeApril 18, 2025, 11:00 a.m. | Kathleen Millen, Ph.D., Professor, Department of Pediatrics/Genetics, Associate Director and Principal Investigator, Seattle Children's Hospital Research Institute, The University of Washington School of Medicine | Co-Sponsored by the Center for Neurobiology Research, Fralin Biomedical Research Institute
-
Home Item
Molecular and Neurobiological Studies in Rett Syndrome and Other MECP2 Disorders , homeMay 1, 2025, 5:30 p.m. (Reception at 5 p.m.) | Huda Zoghbi, M.D., Professor, Pediatrics, Molecular and Human Genetics, Neuroscience, and Neurology; Director, Jan and Dan Duncan Neurological Research Institute, Baylor College of Medicine; Member, National Academy of Medicine | Maury Strauss Distinguished Public Lecture
-
Home Item
A Novel Bispecific Antibody to Target the Brain Tumor Microenvironment , homeMay 2, 2025, 11:00 a.m. | Khuson Yun, Ph.D., Associate Professor, Department of Neurology, Houston Methodist Chair, Neurodegenerative Disease Research, Houston Methodist Research Institute, Weill Cornell Medical College | Co-Sponsored by the Fralin Biomedical Research Institute Cancer Research Center – Roanoke
-
Home Item
Transformation of Information from the External World by Cortical Circuits During Learning , homeMay 9, 2025, 11:00 a.m. | Alison Barth, Ph.D., Professor, Department of Biological Sciences, Carnegie Mellon University | Co-Sponsored by the Center for Neurobiology Research, Fralin Biomedical Research Institute
-
Home Item
The Role of Exercise in Memory Function , homeMay 23, 2025, 11:00 a.m. | Henriette van Praag, Ph.D., Associate Professor, Department of Biomedical Science, Charles E. Schmidt College of Medicine, Florida Atlantic University | Co-Sponsored by the Center for Exercise Medicine Research, Fralin Biomedical Research Institute
Evan Scott, Ph.D.
Kay Davis Professor of Biomedical Engineering and Microbiology-Immunology in the Robert R. McCormick School of Engineering and Applied Science at Northwestern Medicine Feinberg School of Medicine